Dynamic Wealth Strategies’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$81.7K Sell
300
-215
-42% -$55.9K 0.04% 126
2026
Q2
$128K Hold
515
– – 0.07% 109
2026
Q1
$103K Hold
515
– – 0.06% 118
2025
Q4
$106K Buy
515
+50
+11% +$10K 0.06% 114
2025
Q3
$83.4K Hold
465
– – 0.06% 113
2025
Q2
$75K Hold
465
– – 0.05% 110
2025
Q1
$79.1K Buy
+465
New +$80.8K 0.07% 110
2024
Q4
– Sell
-318
Closed -$55K – 126
2024
Q3
$55K Hold
318
– – 0.04% 123
2024
Q2
$49K Hold
318
– – 0.04% 123
2024
Q1
$49K Hold
318
– – 0.04% 128
2023
Q4
$50.3K Buy
+318
New +$45.7K 0.05% 121

Other funds holding FBT

Dynamic Wealth Strategies's FBT Position: Q3 2026 in Review

Dynamic Wealth Strategies reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 42% in Q3 2026, selling an estimated $55.9K and leaving 300 shares worth $81.7K. The position accounts for 0.04% of the portfolio, ranked #126.

Dynamic Wealth Strategies first reported a position in FBT in Q4 2023 and has held it in 11 quarters since. The position peaked at $128K in Q2 2026. 82 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

  • Dynamic Wealth Strategies held 300 shares of First Trust NYSE Arca Biotechnology Index Fund worth $81.7K as of Q3 2026.
  • Dynamic Wealth Strategies sold 215 First Trust NYSE Arca Biotechnology Index Fund shares in Q3 2026, an estimated $55.9K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.04% of Dynamic Wealth Strategies's portfolio in Q3 2026, its #126 holding.
  • Dynamic Wealth Strategies first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2023 and has held it in 11 quarters since.
  • Dynamic Wealth Strategies's First Trust NYSE Arca Biotechnology Index Fund position peaked at $128K in Q2 2026.
  • 82 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on Dynamic Wealth Strategies's 13F filing for Q3 2026, filed 16 Oct 2026.